Population Medicine and Control of Epidemics

  • Hafid BenchaouiEmail author
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 199)


Population medicine is an important component of veterinary care in livestock (farm animals) and companion animals (pets). This chapter covers some of the chemotherapeutic approaches undertaken at population level to control infectious diseases in domestic animals. Optimisation of health, productivity and welfare in livestock commonly entails implementation of whole-herd or whole-flock strategies to effectively counter the negative impact of infectious diseases. Gastro-intestinal and liver parasites of grazing cattle and sheep are endemic in most parts of the world and can result in significant production losses. Strategically timed anthelmintic treatments are instituted with the double objective of reducing worm burdens in infected animals and ensuring reduction of pasture contamination with infective larvae. Mastitis is another major endemic problem, particularly in cattle, which causes significant economic losses to dairy farmers globally. As a painful inflammatory condition of the cow’s udder, clinical mastitis also raises animal welfare concerns. Prevention of clinical mastitis requires rigorous post-milking hygiene, identification and culling of chronically infected cows, attention to the cow’s environment and therapeutic management of udder health during the dry period. A third condition that can cause high levels of morbidity and mortality is bacterial respiratory disease. Pneumonia in young livestock is often exacerbated by stressful transportation and co-mingling of animals from different herds. The welfare consequences and production losses can be significant. Antimicrobial treatment of pneumonic animals and, when appropriate, of in-contact animals living in the same air-space is an integral part of whole-herd respiratory disease management. The role of the veterinary profession is to also ensure that principles of population medicine are understood and adhered to by pet owners. The increase in pet ownership and the importance of the human–animal bond in modern developed societies give rise to zoonotic risks, which require vigilance and intervention. Regular internal parasite control in dogs and cats, particularly in endemic areas, contributes to animal welfare and minimises public health hazards.


Bovine respiratory disease Group therapy Helminths Mastitis Public health Swine respiratory disease 


  1. American Heartworm
  2. Aarestrup FM, Seyfarth AM, Angen Ø (2004) Antimicrobial susceptibility of Haemophilus parasuis and Histophilus somni from pigs and cattle in Denmark. Vet Microbiol 101:143–146PubMedGoogle Scholar
  3. Alvarez-Sánchez MA, Pérez-García J, Cruz-Rojo MA, Rojo-Vázquez FA (2006) Anthelmintic resistance in trichostrongylid nematodes of sheep farms in Northwest Spain. Parasitol Res 99:78–83PubMedGoogle Scholar
  4. Alvinerie M, Sutra JF, Galtier P, Mage C (1999) Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle. Res Vet Sci 67:229–232PubMedGoogle Scholar
  5. Anadón A, Martinez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M (1999) Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. Am J Vet Res 60:1377–1382PubMedGoogle Scholar
  6. Arcangioli M-A, Duet A, Meyer G, Dernburg A, Bézille P, Poumarat F, Le Grand D (2008) The role of Mycoplasma bovis in bovine respiratory disease outbreaks in veal calf feedlots. Vet J 177:89–93PubMedGoogle Scholar
  7. Ayling RD, Baker SE, Nicholas RAJ, Peek ML, Simon AJ (2000) Comparsion of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Vet Rec 146:745–747Google Scholar
  8. Bartley DJ, Jackson E, Johnston K, Coop RL, Mitchell GB, Sales J, Jackson F (2003) A survey of resistant nematode parasites in Scottish sheep flocks. Vet. Parasitol 117:61–71PubMedGoogle Scholar
  9. Bauer C, Fiege N, Klatte D, Enninga J, Burger HJ (1988) Field studies on anthelmintic resistance of trichostrongylidae in sheep flock in Hessen. Berl Munch Tierarztl Wochenschr 101:185–189PubMedGoogle Scholar
  10. Benchaoui HA, Nowakowski M, Sherington J, Rowan T, Sunderland SJ (2004) Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Ther 27:203–210PubMedGoogle Scholar
  11. Bjørn H, Monrad J, Nansen P (1991) Anthelmintic resistance in nematode parasites of sheep in Denmark with special emphasis on levamisole resistance in Ostertagia circumcincta. Acta Vet Scand 32:145–154PubMedGoogle Scholar
  12. Booth JM (1988) Progress in controlling mastitis in England and Wales. Vet Rec 122:299–302PubMedGoogle Scholar
  13. Borgsteede FHM, Derckson DD, Huijbers R (2007) Doramectin and albendazole resistance in sheep in The Netherlands. Vet Parasitol 144:180–183PubMedGoogle Scholar
  14. Bowman DD, Lynn RC, Eberhard ML, Georgi JR (2003) Georgis’ parasitology for veterinarians. Saunders, St. Louis, pp 422Google Scholar
  15. Bradley A, Huxley J, Green M (2003) A rational approach to dry cow therapy 2. Product Selection. In Practice 25:12–17Google Scholar
  16. Brennan GP, Fairweather I, Trudgett A, Hoey E, McCoy M, McConville M, Meaney M, Robinson M, McFerran N, Ryan L, Lanusse C, Mottier L, Alvarez H, Solana H, Virkel G, Brophy PM (2007) Understanding triclabendazole resistance. Exp Mol Pathol 82:104–109PubMedGoogle Scholar
  17. Brown SA, Hanson BJ, Mignot A, Millérioux L, Hamlow PJ, Humbbard VL, Callahan JK, Kausche FM (1999) Comparison of plasma pharmacokinetics and bioavailability of ceftiofur sodium and ceftiofur hydrochloride in pigs after a single intramuscular injection. J Vet Pharmacol Ther 22:35–40PubMedGoogle Scholar
  18. Brown SA, Chester ST, Speedy AK, Hubbard VL, Callahan JK, Hamlow PJ, Hibbard B, Robb EJ (2000) Comparison of plasma pharmacokinetics and bioequivalence of ceftiofur sodium in cattle after a single intramuscular or subcutaneous injection. J Vet Pharmacol Ther 23:273–280PubMedGoogle Scholar
  19. Budke CM, Deplazes P, Torgerson PR (2006) Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis 12:296–303PubMedGoogle Scholar
  20. Catry B, Duchateau L, Van De Ven J, Laevens H, Opsomer G, Haesebrouck F, De Kruif A (2008) Efficacy of metaphylactic florfenicol therapy during natural outbreaks of bovine respiratory disease. J Vet Pharmacol Ther 31:479–487PubMedGoogle Scholar
  21. Čerňanská D, Várady M, Čorba J (2006) A survey on anthelmintic resistance in nematode parasites of sheep in the Slovak Republic. Vet Parasitol 135:39–45PubMedGoogle Scholar
  22. Coles GC, Stafford KA, MacKay PH (1998) Ivermectin-resistant Cooperia species from calves on a farm in Somerset. Vet Rec 142:255–256PubMedGoogle Scholar
  23. Coles GC, Watson CL, Anziani OS (2001) Ivermectin-resistant Cooperia in cattle. Vet. Rec. 148:283–284PubMedGoogle Scholar
  24. Coles GC, Jackson F, Pomroy WE, Prichard RK, von Samson-Himmelstjerna G, Silvestre A, Taylor MA, Vercruysse J (2006) The detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol 136:167–185PubMedGoogle Scholar
  25. Davis JL, Foster DM, Papich MG (2007) Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. J Vet Pharmacol Ther 30:564–571PubMedGoogle Scholar
  26. Demeler J, Van Zeveren AM, Kleinschmidt N, Vercruysse J, Höglund J, Koopmann R, Cabaret J, Claerebout E, Areskog M, von Samson-Himmelstjerna G (2009) Monitoring the efficacy of ivermectin and albendazole against gastro intestinal nematodes of cattle in Northern Europe. Vet Parasitol 160:109–115PubMedGoogle Scholar
  27. Deplazes P, Eckert J (2001) Veterinary aspects of alveolar echinococcosis – a zoonosis of public health significance. Vet Parasitol 98:65–87PubMedGoogle Scholar
  28. Díez-Baños P, Pedreira J, Sánchez-Andrade R, Francisco I, Suárez JL, Díaz P, Panadero R, Arias M, Painceira A, Paz-Silva A, Morrondo P (2008) Field evaluation for anthelmintic-resistant ovine gastrointestinal nematodes by in vitro and in vivo assays. J Parasitol 94:925–928PubMedGoogle Scholar
  29. Done SH (1991) Environmental factors affecting the severity of pneumonia in pigs. Vet Rec 128:582–586PubMedGoogle Scholar
  30. Done S, White M (2003) Porcine respiratory disease and complexes: the story to date. In Practice 25:410–417Google Scholar
  31. Duwel D, Schmid K, Bechmann G (1987) Benzimidazole-resistant Haemonchus contortus in sheep in West Germany. Berl Munch Tierarztl Wochenschr 100:120–123PubMedGoogle Scholar
  32. Dyachenko V, Pantchev N, Gawlowska S, Globokar Vrhovec M, Bauer C (2008) Echinococcus multilocularis infections in domestic dogs and cats from Germany and other European countries. Vet Parasitol 157:244–253PubMedGoogle Scholar
  33. El Korchi G, Prats C, Arboix M, Pérez B (2001) Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations. J Vet Pharmacol Ther 24:247–250PubMedGoogle Scholar
  34. Esccap (European Scientific Counsel Companion Animal Parasites) (2006) Worm control in dogs and cats.
  35. Friton GM, Cajal C, Ramirez-Romero R (2005) Long-term effects of meloxicam in the treatment of respiratory disease in fattening cattle. Vet Rec 156:809–811PubMedGoogle Scholar
  36. Gayrard V, Alvinerie M, Toutain PL (1999) Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle. Vet Parasitol 81:47–55PubMedGoogle Scholar
  37. Genchi C, Rinaldi L, Cascone C, Mortarino M, Cringoli G (2005) Is heartworm disease really spreading in Europe? Vet Parasitol 133:137–148PubMedGoogle Scholar
  38. Gibb MJ, Huckle CA, Forbes AB (2005) Effects of sequential treatments with eprinomectin on performance and grazing behaviour in dairy cattle under daily-paddock stocking management. Vet Parasitol 133:29–90Google Scholar
  39. Gibbs A (2001) Practical approach to the control of pneumonia in housed calves. In Practice 23:32–39Google Scholar
  40. Godinho KS (2008) Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates. Vet Microbiol 129:426–432PubMedGoogle Scholar
  41. Godinho KS, Keane SG, Nanjiani IA, Benchaoui HA, Sunderland SJ, Jones MA, Weatherley AJ, Gootz TD, Rowan TG (2005a) Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet Ther 6:114–121Google Scholar
  42. Godinho KS, Wolf RM-L, Sherington J, Rowan TG, Sunderland SJ, Evans NA (2005b) Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle. Vet Ther 6:122–135PubMedGoogle Scholar
  43. Green M, Huxley J, Bradley A (2002) A rational approach to dry cow therapy 1. Udder health priorities during the dry period. In Practice 24:582–587Google Scholar
  44. Gross SJ, Ryan WG, Ploeger HW (1999) Anthelmintic treatment of dairy cows and its effect on milk production. Vet Rec 144:581–587PubMedGoogle Scholar
  45. Hannan PCT, Windsor HM, Ripley PH (1997) In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor®), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae. Res Vet Sci 63:157–160PubMedGoogle Scholar
  46. Hegglin D, Ward PI, Deplazes P (2003) Anthelmintic baiting of foxes against urban contamination with Echnicococcus multiloculari. Emerg Infect Dis 9:1266–1273PubMedGoogle Scholar
  47. Hendrix CM, Bruce HS, Kellman NJ, Harrelson G, Bruhn BF (1996) Cutaneous larva migrans and enteric hookworm infections. J Am Vet Med Assoc 209:1763–1767PubMedGoogle Scholar
  48. Hillerton E, Berry EA (2005) Treating mastitis in the cow – a tradition or an archaism. J Appl Microbiol 98:1250–1255PubMedGoogle Scholar
  49. Höglund J, Gustafsson K, Ljungström BL, Engström A, Donnan A, Skuce P (2009) Anthelmintic resistance in Swedish sheep flocks based on a comparison of the results from the faecal egg count reduction test and resistant allele frequencies of the beta-tubulin gene. Vet Parasitol 161:60–68PubMedGoogle Scholar
  50. Inoue T, Nonaka N, Kanai Y, Iwaki T, Kamiya M, Oku Y (2007) The use of tetracycline in anthelmintic baits to assess baiting rate and drug efficacy against Echnicococcus multilocularis in foxes. Vet Parasitol 150:88–96PubMedGoogle Scholar
  51. Jiang HX, Zeng ZL, Chen ZL, Liu JJ, Fung KF (2006) Pharmacokinetics of florfenicol in pigs following intravenous, intramuscular or oral administration and the effects of feed intake on oral dosing. J Vet Pharmacol Ther 29:153–156PubMedGoogle Scholar
  52. Jones T, Ohnstad I (2002) Milking procedures recommended for the control of bovine mastitis. In Practice 24:502–511Google Scholar
  53. Jones RN, Pfaller MA, Rhomberg PR, Walter DH (2002) Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods. Antimicrob Agents Chemother 40:461–465Google Scholar
  54. Kadlec K, Kehrenberg C, Wallmann J, Schwarz S (2004) Antimicrobial susceptibility of Bordetella bronchiseptica isolates from porcine respiratory tract infections. Antimicrob Agents Chemother 48:4903–4906PubMedGoogle Scholar
  55. Kaminsky R, Ducray P, Jung M, Clover R, Rufener L, Bouvier J, Shorderet Weber S, Wenger A, Wieland-Berghausen S, Goebel T, Gauvry N, Pautrat F, Skripsky T, Froelich O, Komoin-Oka C, Westlund B, Sluder A, Mäser P (2008) A new class of anthelmintics effective against drug-resistant nematodes. Nature 452:176–180PubMedGoogle Scholar
  56. Kaplan RM (2004) Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol 20:477–481PubMedGoogle Scholar
  57. Kehrenberg C, Mumme J, Wallmann J, Verspohl J, Tegeler R, Kühn T, Schwarz S (2004) Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003. J Antimicrob Chemother 54:572–574PubMedGoogle Scholar
  58. Kleinschmidt N, von Samson-Himmelstjema G, Demeler J, Koopmann R (2008) Incidence of anthelmintic resistance in cattle farms in Northern Germany – first results. 16th IFOAM Organic World Congress, Modena, Italy, June 16–20Google Scholar
  59. Kopp SR, Kotze AC, McCarthy JS, Traub RJ, Coleman GT (2008) Pyrantel in small animal medicine: 30 years on. Vet J 178:177–184PubMedGoogle Scholar
  60. Kopp SR, Coleman GT, Traub RJ, McCarthy JS, Kotze AC (2009) Acetylcholine receptor subunit genes from Ancylostoma caninum: Altered transcription patterns associated with pyrantel resistance. Int J Parasitol 39:435–441PubMedGoogle Scholar
  61. Lifschitz A, Virkel G, Sallovitz J, Imperiale F, Pis A, Lanusse C (2002) Loperamide-induced enhancement of moxidectin availability in cattle. J Vet Pharmacol Ther 25:111–120PubMedGoogle Scholar
  62. Lobell RD, Varma KJ, Johnson JC, Sams RA, Gerken DF, Ashcraft SM (1994) Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J Vet Pharmacol Ther 17:253–258PubMedGoogle Scholar
  63. Lockwood PW, Johnson JC, Katz TL (2003) Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease. Vet Rec 152:392–394PubMedGoogle Scholar
  64. Magne ML (2006) Selected Topics in Pediatric Gastroenterology. Vet Clin Small Anim 36:533–548Google Scholar
  65. Maingi N, Bjørn H, Thamsborg SM, Bøgh HO, Nansen P (1997) A survey of anthelmintic resistance in nematode parasites of goats in Denmark. Small Rum Res 23:171–181Google Scholar
  66. McCall JW (2005) The safety-net story about macrocyclic lactone heartworm preventives: A review, update, and recommendations. Vet Parasitol 133:197–206PubMedGoogle Scholar
  67. McCall JW, Genchi C, Kramer L, Guerrero J, Dzimianski MT, Supakorndej P, Mansour AM, McCall SD, Supakorndej N, Grandi G, Carson B (2008) Heartworm and Wolbachia: Therapeutic implications. Vet Parasitol 158:204–214PubMedGoogle Scholar
  68. McKellar QA, Benchaoui HA (1996) Avermectins and milbemycins. J Vet Pharmacol Ther 19:331–351PubMedGoogle Scholar
  69. Mitchell GBB (2002) Update on fasciolosis in cattle and sheep. In Practice 24:378–385Google Scholar
  70. Modric S, Webb AI, Derendorf H (1998) Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J Vet Pharmacol Ther 21:444–452PubMedGoogle Scholar
  71. Newton HT, Green MJ, Benchaoui H, Cracknell V, Rowan T, Bradley AJ (2008) Comparison of the efficacy of cloxacillin alone and cloxacillin combined with an internal teat sealant for dry cow therapy. Vet Rec 162:678–684PubMedGoogle Scholar
  72. Nicholas RAJ, Ayling RD (2003) Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci 74:105–112PubMedGoogle Scholar
  73. Nieuwhof GJ, Bishop SC (2005) Costs of the major endemic diseases of sheep in Great Britain and the potential benefits of reduction in disease impact. Anim Sci 81:23–29Google Scholar
  74. Nowakowski MA, Inskeep PB, Risk JE, Skogerboe TL, Benchaoui HA, Meinert TR, Sherington J, Sunderland SJ (2004) Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 5:60–74PubMedGoogle Scholar
  75. O’Brien DJ, Strickland KL, Parr SL, Gray JS, O'Reilly PF, Clements L, Dwyer PJ, O'Reilly LM, Coles GC, Borgsteede FHM, Geerts S. (1994) Anthelmintic resistant nematodes in farm animals in Ireland. In: Coles GC, Borgsteede FHM (eds) Anthelmintic resistance in nematodes of farm animals. A Seminar Organized for the European Commission, Brussels, November 8–9, pp 101–106Google Scholar
  76. Oliver SP (1998) Frequency of isolation of environmental mastitis causing pathogens and incidence of new intramammary infection during the non-lactating period. Am J Vet Res 49:1789–1793Google Scholar
  77. Palcy C, Silvestre A, Sauve C, Cortet J, Cabaret J (2010) Benzimidazole resistance in Trichostrongylus axei in sheep: long-term monitoring of affected sheep and genotypic evaluation of the parasite. Vet J 183:68–74PubMedGoogle Scholar
  78. Papadopoulos E, Himonas C, Coles GC (2001) Drought and flock isolation may enhance the development of anthelmintic resistance in nematodes. Vet Parasitol 97:253–259PubMedGoogle Scholar
  79. PARASOL project.
  80. Patten T, Good B, Hanrahan JP, De Waal DT (2007) A survey on anthelmintic resistance in lowland sheep flocks in Ireland. Agricultural Research Forum, OnlineGoogle Scholar
  81. Potter T (2007) Calf pneumonia. UK Vet 12:1–3Google Scholar
  82. Priebe S, Schwarz S (2003) In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob Agents Chemother 47:2703–2705PubMedGoogle Scholar
  83. Pyörälä S (2008) Mastitis in post-partum dairy cows. Reprod Domest Anim 43(Suppl 2): 252–259PubMedGoogle Scholar
  84. Rosenbusch RF, Kinyon JM, Apley M, Funk ND, Smith S, Hoffman LJ (2005) In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. J Vet Diagn Invest 17:436–441PubMedGoogle Scholar
  85. SAC Veterinary Services (2008) High incidence of endoparasitic diseases in cattle and sheep in Scotland. Vet Rec 163:469–472Google Scholar
  86. Sallovitz JM, Lifschitz A, Imperiale F, Virkel G, Lanusse C (2003) A detailed assessment of the pattern of moxidectin tissue distribution after pour-on treatment in calves. J Vet Pharmacol Ther 26:397–404PubMedGoogle Scholar
  87. Salmon SA, Watts JL, Yancey RJ (1996) In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance. J Vet Diagn Invest 8:332–336PubMedGoogle Scholar
  88. Sargison ND, Scott PR, Jackson F (2001) Multiple anthelmintic resistance in sheep. Vet Rec 149:778–779PubMedGoogle Scholar
  89. Sargison ND, Jackson F, Bartley DJ, Moir AC (2005) Failure of moxidectin to control benzimidazole-, levamisole- and ivermectin-resistant Teladorsagia circumcincta in a sheep flock. Vet Rec 156:105–109PubMedGoogle Scholar
  90. Sargison ND, Jackson F, Bartley DJ, Wilson DJ, Stenhouse LJ, Penny CD (2007) Observations on the emergence of multiple anthelmintic resistance in sheep flocks in the south east of Scoltand. Vet Parasitol 145:65–76PubMedGoogle Scholar
  91. Schifferli D, Galeazzi RL, Nicolet J, Wanner M (1982) Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves. J Vet Pharmacol Ther 5:247–257PubMedGoogle Scholar
  92. Schwarz S, Kehrenberg C, Salmon SA, Watts JL (2004) In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle. J Antimicrob Chemother 53:379–382PubMedGoogle Scholar
  93. Scott PR, Sargison ND, Wilson DJ (2007) The potential for improving welfare standards and productivity in United Kingdom sheep flocks using veterinary flock health plans. Vet J 173:522–531PubMedGoogle Scholar
  94. Smith A, Westgarth DR, Jones MR, Neave FK, Dodd FH, Brander GC (1967) Methods of reducing the incidence of udder infections in dry cows. Vet Rec 81:504–510PubMedGoogle Scholar
  95. Stoneham S, Coles G (2006) Ivermectin resistance in Parascaris equorum. Vet Rec 158:572PubMedGoogle Scholar
  96. Tackmann K, Löschner U, Mix H, Staubach C, Thulke H-H, Ziller M, Conraths FJ (2001) A field study to control Echinococcus multilocularis-infections of the red fox (Vulpes vulpes) in an endemic focus. Epidemiol Infect 127:577–587PubMedGoogle Scholar
  97. Taylor MRH, Holland CV (2001) Toxocariasis. In: Gillespie SH, Pearson RD (eds) Principles and practice of clinical parasitology. Wiley, New York, pp 501–522Google Scholar
  98. TerHune TN, Skogerboe TL, Shostrom VK, Weigel DJ (2005) Comparison of pharmacokinetics of danofloxacin and enrofloxacin in calves challenged with Mannheimia haemolytica. Am J Vet Res 66:342–349PubMedGoogle Scholar
  99. Theis TH (2005) Public health aspects of dirofilariasis in the United States. Vet Parasitol 133:157–180PubMedGoogle Scholar
  100. Thomson K, Rantala M, Hautala M, Pyörälä S, Kaartinen L (2008) Cross-sectional prospective survey to study indication-based usage of antimicrobials in animals: results of use in cattle. BMC Vet Res 4:15PubMedGoogle Scholar
  101. Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Tarr PE, Halkik N, Müllhaupt B (2008) Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Swizerland over the last 35 years. J Hepatol 49:72–77PubMedGoogle Scholar
  102. Toutain PL, Upson DW, Terhune TN, McKenzie ME (1997) Comparative pharmacokinetics of doramectin and ivermectin in cattle. Vet Parasitol 72:3–8PubMedGoogle Scholar
  103. Traill P (2008) Parascaris equorum resistance to moxidectin? Vet Rec 162:491PubMedGoogle Scholar
  104. Traversa D, Klei TR, Iorio R, Paoletti B, Lia RP, Otranto D, Sparagano OAE, Giangaspero A (2007a) Occurence of anthelmintic resistant equine cyathostome populations in central and southern Italy. Prev Vet Med 82:314–320PubMedGoogle Scholar
  105. Traversa D, Paoletti B, Otranto D, Miller J (2007b) First report of multiple drug resistance in trichostongyles affecting sheep under field conditions in Italy. Parasitol Res 101:1713–1716PubMedGoogle Scholar
  106. Van Donkersgoed J, Merrill J, Hendrick S (2008) Comparative efficacy of tilmicosin versus tulathromycin as a metaphylactic antimicrobial in feedlot calves at moderate risk for respiratory disease. Vet Therap 9:291–297Google Scholar
  107. van Wyk JA, Hoste H, Kaplan RM, Besier RB (2006) Targeted selective treatment for worm management – how do we sell rational programs to farmers. Vet Parasitol 139:336–346PubMedGoogle Scholar
  108. Venco L, Genchi C, Genchi M, Grandi G, Kramer LH (2008) Clinical evolution and radiographic findings of feline heartworm infection in asymptomatic cats. Vet Parasitol 158:232–237PubMedGoogle Scholar
  109. Vercruysse J, Dorny P, Meurrens K (1989) Benzimidazole resistance of nematodes in sheep in Belgium. Vet Rec 125:602–603PubMedGoogle Scholar
  110. Vicca J, Stakenborg T, Maes D, Butaye P, Peeters J, de Kruif A, Haesebrouck F (2004) In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates. Antimicrob Agents Chemother 48:4470–4472PubMedGoogle Scholar
  111. Waller PJ (2006) From discovery to development: Current industry perspectives for the development of novel methods of helminth control in livestock. Vet Parasitol 139:1–14PubMedGoogle Scholar
  112. Wicks SR, Kaye B, Weatherley AJ, Lewis D, Davison E, Gibson SP, Smith DG (1993) Effect of formulation on the pharmacokinetics and efficacy of doramectin. Vet Parasitol 49:17–26PubMedGoogle Scholar
  113. Wilkinson PK, Pope DG, Baylis FP (1985) Pharmacokinetics of ivermectin administered intravenously to cattle. J Pharm Sci 74:1105–1107PubMedGoogle Scholar
  114. Ziv G (1980) Drug selection and use in mastitis: systemic versus local therapy. J Am Vet Med Assoc 176:1109–1128PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Novartis Animal Health Inc.BaselSwitzerland

Personalised recommendations